Skip to main content
Caplight Logo









Salú

Salú

Private
São PauloHealthcare & Life Scienceshttps://salu.com.vc

Last Round

Seed

Mar 29, 2022

Total Funding Raised

$2.41M

Company Overview

Salú operates in Healthcare & Life Sciences and is based in São Paulo. Its latest recorded funding round was a Seed round in March 2022.

Salú is a healthtech company that provides an integrated SaaS platform and specialized services for corporate occupational health and safety management.

Sector

Healthcare & Life Sciences

Verticals

HR, Compliance, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Salú Comparables

Compare Salú with similar companies based on industry and business-model similarity.

Salú comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BeeCorp - Bem Estar Corporativo
85%
AGE Tecnologia
83%
Sankhya
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Salú Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 29, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Ricardo Silveira Junior

Co-Founder & Chief Revenue Officer (CRO)

Founding Team

For institutional investors. Book with your work email.

Salú Investors

Notable investors and investment history

Salú investors
InvestorRounds
Norte VenturesSeed
Tau VenturesSeed
SoftBank SBLA Advisers Corp.Seed
Aggir VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 85% MoM.

  • Jan 1, 2026

    Monthly visitors increased 39% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Salú Filings

Explore SEC and related filing metadata, where available.

Salú filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Salú's valuation, stock price, and market status.

Is Salú a public or private company?

Salú is a private company.

What is the current stock price of Salú?

Salú is a private company, so its shares have no public market price. Caplight tracks Salú's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Salú worth (valuation)?

Valuation information for Salú is not publicly available.

Can I buy Salú stock?

Salú shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Salú's last funding round?

Salú's most recent funding round was Seed on March 29, 2022.

Who are the main investors in Salú?

Key investors in Salú include SoftBank SBLA Advisers Corp..

Will Salú IPO soon?

No public IPO plans have been announced for Salú.

How can I track Salú secondary market activity?

Caplight tracks bids, offers, and trades in Salú's shares on secondary markets.

Firmographic Details

HeadquartersSão Paulo
Employee Range217
Year Founded2020
Last FundingMar 29, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?